The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ann Eldred, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
71 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 8493
Adelaide, Australia
- Site Reference Id/investigator# 8506
Liverpool, Australia
- Site Reference Id/investigator# 8507
Parkville, Australia
- Site Reference Id/investigator# 9581
Reservoir, Australia
- Site Reference Id/investigator# 9582
Richmond, Australia
- Site Reference Id/investigator# 8500
Westmead, Australia
- Site Reference Id/investigator# 8245
Prague, Czechia
- Site Reference Id/investigator# 8246
Prague, Czechia
- Site Reference Id/investigator# 8499
Prague, Czechia
- Site Reference Id/investigator# 6692
Dortmund, Germany
- Site Reference Id/investigator# 9723
Düsseldorf, Germany
- Site Reference Id/investigator# 6630
Lübeck, Germany
- Site Reference Id/investigator# 7268
Nettetal, Germany
- Site Reference Id/investigator# 6622
Würzburg, Germany
- Site Reference Id/investigator# 10626
Lido di Camaiore, Italy
- Site Reference Id/investigator# 8070
Naples, Italy
- Site Reference Id/investigator# 8060
Rome, Italy
- Site Reference Id/investigator# 8519
Lodz, Poland
- Site Reference Id/investigator# 7702
Humacao, Puerto Rico
- Site Reference Id/investigator# 7269
Ponce, Puerto Rico
- Site Reference Id/investigator# 7818
Rio Piedras, Puerto Rico
- Site Reference Id/investigator# 7270
San Juan, Puerto Rico
- Site Reference Id/investigator# 7712
San Juan, Puerto Rico
- Site Reference Id/investigator# 7266
Toa Baja, Puerto Rico
- Site Reference Id/investigator# 8518
Bucharest, Romania
- Site Reference Id/investigator# 8881
Bucharest, Romania
- Site Reference Id/investigator# 8514
Iași, Romania
- Site Reference Id/investigator# 22682
Moscow, Russia
- Site Reference Id/investigator# 7250
Moscow, Russia
- Site Reference Id/investigator# 7251
Moscow, Russia
- Site Reference Id/investigator# 8009
Moscow, Russia
- Site Reference Id/investigator# 8358
Barcelona, Spain
- Site Reference Id/investigator# 8883
Barcelona, Spain
- Site Reference Id/investigator# 8355
Madrid, Spain
- Site Reference Id/investigator# 8356
Madrid, Spain
- Site Reference Id/investigator# 8882
Santander (Cantabria), Spain
- Site Reference Id/investigator# 8228
Taipei, Taiwan
- Site Reference Id/investigator# 8884
Taipei, Taiwan
- Site Reference Id/investigator# 8229
Taoyuan, Taiwan
- Site Reference Id/investigator# 8234
Xinzhuang, Taiwan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2008
- Primary completion
- 30 Sept 2010
- Completion
- 31 Mar 2012
- Last update posted
- 12 Mar 2013
- Registered enrollment
- 227
- Registry id
- NCT00497146
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.